Special Drug Use-results Survey for Long-term Use (Fostamatinib)

Kissei

Status: Enrolling

Conditions: Chronic Idiopathic Thrombocytopenic Purpura

Treatments: Drug: fostamatinib

Study type: Observational

Funder types: Industry

Identifiers

NCT06757257

TLPMS01

Details and patient eligibility

About

The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.

Full description

The purpose of this survey is evaluating the safety and efficacy of long-term administration of fostamatinib for Japanese patients with chronic idiopathic thrombocytopenic purpura under actual conditions of use.

Enrollment: 149 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with chronic idiopathic thrombocytopenic purpura who are treatment with fostamatinib for the first time.

Trial design

149 participants in 1 patient group

fostamatinib treatmented

Treatment:

Drug: fostamatinib